Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 29c
Tweet
Share
E-mailGet Alerts TARA Hot Sheet
Join SI Premium – FREE
Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.68), $0.29 better than the analyst estimate of ($0.97).
For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
- Evolution Petroleum launches stock offering to fund Permian Basin deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
